241 related articles for article (PubMed ID: 19060535)
1. Out with the old, in with the new: immunosuppression minimization in children.
Sarwal MM
Curr Opin Organ Transplant; 2008 Oct; 13(5):513-21. PubMed ID: 19060535
[TBL] [Abstract][Full Text] [Related]
2. Long-term maintenance therapy with calcineurin inhibitors: an update.
Campistol JM
Transplant Proc; 2010 Nov; 42(9 Suppl):S21-4. PubMed ID: 21095445
[TBL] [Abstract][Full Text] [Related]
3. Evidence for immunosuppression in lung transplantation.
Hopkins PM; McNeil K
Curr Opin Organ Transplant; 2008 Oct; 13(5):477-83. PubMed ID: 19060529
[TBL] [Abstract][Full Text] [Related]
4. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
[TBL] [Abstract][Full Text] [Related]
5. Can the early elimination of calcineurin inhibitors result in clinical benefits?
Weir MR
Transplant Proc; 2010 Nov; 42(9 Suppl):S16-20. PubMed ID: 21095444
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of everolimus with calcineurin inhibitor-free immunosuppression in maintenance heart transplant patients: results at 2 years.
Engelen MA; Amler S; Welp H; Vahlhaus C; Gunia S; Sindermann JR; Rothenburger M; Stypmann J
Transplantation; 2011 May; 91(10):1159-65. PubMed ID: 21478817
[TBL] [Abstract][Full Text] [Related]
7. Everolimus and minimization of cyclosporine in renal transplantation: 24-month follow-up of the EVEREST study.
Ponticelli C; Salvadori M; Scolari MP; Citterio F; Rigotti P; Veneziano A; Bartezaghi M;
Transplantation; 2011 May; 91(10):e72-3. PubMed ID: 21540717
[No Abstract] [Full Text] [Related]
8. Steroid avoidance or withdrawal in kidney transplantation.
Pascual J
Curr Opin Organ Transplant; 2011 Dec; 16(6):600-5. PubMed ID: 21971514
[TBL] [Abstract][Full Text] [Related]
9. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
[TBL] [Abstract][Full Text] [Related]
10. Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?
Wali RK; Weir MR
Curr Opin Organ Transplant; 2008 Dec; 13(6):614-21. PubMed ID: 19060552
[TBL] [Abstract][Full Text] [Related]
11. What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus?
Hanto DW; Chudzinski R
Transplantation; 2009 Jan; 87(2):164-5. PubMed ID: 19155968
[No Abstract] [Full Text] [Related]
12. Rationale and criteria of eligibility for calcineurin inhibitor interruption following kidney transplantation.
Danger R; Giral M; Soulillou JP; Brouard S
Curr Opin Organ Transplant; 2008 Dec; 13(6):609-13. PubMed ID: 19060551
[TBL] [Abstract][Full Text] [Related]
13. Advances in immunosuppression for pancreas transplantation.
Singh RP; Stratta RJ
Curr Opin Organ Transplant; 2008 Feb; 13(1):79-84. PubMed ID: 18660711
[TBL] [Abstract][Full Text] [Related]
14. Steroid-free maintenance immunosuppression and ABO-incompatible transplantation.
Gloor J; Matas AJ
Transplantation; 2010 Mar; 89(6):648-9. PubMed ID: 20010327
[No Abstract] [Full Text] [Related]
15. CNIs: immediate benefits but storing problems for the future?
Kiuchi T
Transplantation; 2008 Oct; 86(8):1026-7. PubMed ID: 18946338
[TBL] [Abstract][Full Text] [Related]
16. Maintenance immunosuppression regimens: conversion, minimization, withdrawal, and avoidance.
Yang H
Am J Kidney Dis; 2006 Apr; 47(4 Suppl 2):S37-51. PubMed ID: 16567240
[TBL] [Abstract][Full Text] [Related]
17. Immunological risks of minimization strategies.
Snanoudj R; Tinel C; Legendre C
Transpl Int; 2015 Aug; 28(8):901-10. PubMed ID: 25809144
[TBL] [Abstract][Full Text] [Related]
18. Calcineurin inhibitors in liver transplantation: to be or not to be.
CastroagudÃn JF; Molina E; Varo E
Transplant Proc; 2011; 43(6):2220-3. PubMed ID: 21839238
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus-based, calcineurin-inhibitor sparing immunotherapy, long-term (6-year) results.
Conti DJ; Petrov R; Elbalhoul O; Gallichio M
Transpl Immunol; 2008 Nov; 20(1-2):12-3. PubMed ID: 18793727
[TBL] [Abstract][Full Text] [Related]
20. Is there such a thing as protocol immunosuppression in liver transplantation?
McCaughan GW; Sze KC; Strasser SI
Expert Rev Gastroenterol Hepatol; 2015 Jan; 9(1):1-4. PubMed ID: 25164689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]